← Leaderboards
David Bernstein
Cincinnati Childrens Hosp Med Ctr
$28,954,781
Attributed
$28,954,781
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.8M · FY2009–22$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$28,954,781 · 5
By mechanism
N01$28,954,781 · 5
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Robert Wilson Frenck$19,500,699
- Robert Frenck$15,335,064
- Sing Sing Way$29,358,207
- Paul W. Spearman$26,612,118
- David Bernstien$7,899,376
Others in their field
Top investigators on “Contracts”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ContractsNamed GroupConduct Clinical TrialsDesignResourcesVaccinesEvaluationInfectious Disease TreatmentRouteInvestigationClinical TrialsCommunicable DiseasesVaccine CandidateProgramsAnimal ModelStandardizationInfluenza Virus VaccineCombatAnimal Model DevelopmentEfficacy TestingVaccine Clinical TrialInfectious Disease ModelLicensureInfluenza
Grant awards (47)
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses$787,888
N01 · FY2022 · AI · contact PI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses$770,712
N01 · FY2021 · AI · contact PI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses$753,986
N01 · FY2020 · AI · contact PI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses$737,729
N01 · FY2019 · AI · contact PI
Vaccine and Treatment Evaluation Units: Phase II Influenza Vaccine Clinical Trial$195,030
N01 · FY2019 · AI · contact PI
Task A05: Small animal models for cytomegalovirus and herpes simplex viruses$736,623
N01 · FY2018 · AI · contact PI
Task A08: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$4,706
N01 · FY2018 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: PHASE I E.COLI VACCINE TRIAL$2,620,417
N01 · FY2017 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS: HANTAVIRUS VACCINE CLINICAL TRIAL$1,278,322
N01 · FY2017 · AI · contact PI
Vaccine and Treatment Evaluation Unit: Phase I Influenza Vaccine Clinical Trial$289,680
N01 · FY2017 · AI · contact PI
Vaccine Treatment and Evaluation Units: Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU$243,329
N01 · FY2017 · AI · contact PI
VACCINE TREATMENT AND EVALUATION UNIT: PHASE II TRIAL FOR BACTERIAL VAGINOSIS$231,807
N01 · FY2017 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$762,539
N01 · FY2016 · AI · contact PI
Task A85 Mouse and Guinea Pig Models for Herpesviruses$754,237
N01 · FY2016 · AI · contact PI
VTEU: Phase I Influenza Vaccine Clinical Trial$617,036
N01 · FY2016 · AI · contact PI
Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU$168,776
N01 · FY2016 · AI · contact PI
VTEU: Phase II Influenza Vaccine Clinical Trial$89,675
N01 · FY2016 · AI · contact PI
Vaccine and Treatment Evaluation Unit Clinical Operations Support$87,588
N01 · FY2016 · AI · contact PI
Task A85 Mouse and Guinea Pig Models for Herpesviruses$734,332
N01 · FY2015 · AI · contact PI
Vaccine and Treatment Evaluation Unit$336,281
N01 · FY2015 · AI · contact PI
Phase IV Trial to Evaluate Antimicrobial Therapy of Community Acquired Pneumonia in Children - VTEU$79,911
N01 · FY2015 · AI · contact PI
Phase II Trial of H7N9 Influenza Vaccines - VTEU$832,511
N01 · FY2014 · AI · contact PI
Task A01 Mouse and Guinea Pig Models for Herpesviruses$651,881
N01 · FY2014 · AI · contact PI
Safety and Immunogenicity of Shigella Vaccines - VTEU$600,083
N01 · FY2014 · AI · contact PI
Vaccine and Treatment Evaluation Units$363,731
N01 · FY2014 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,100,000
N01 · FY2012 · AI · contact PI
Vaccine and Treatment Evaluation Units$1,002,259
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$600,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$600,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2012 · AI · contact PI
Vaccine and Treatment Evaluation Units$300,000
N01 · FY2012 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,100,000
N01 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$1,000,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,000,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$1,000,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$600,000
N01 · FY2011 · AI · contact PI
Task A01 Mouse and Guinea Pig Models for Herpesviruses$588,626
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,014
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$500,000
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$476,679
N01 · FY2011 · AI · contact PI
Vaccine and Treatment Evaluation Units$327,160
N01 · FY2011 · AI · contact PI
VACCINE AND TREATMENT EVALUATION UNITS$250,000
N01 · FY2011 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATIOON OF EXPERIMENTAL THERAPIE$506,233
N01 · FY2010 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATIOON OF EXPERIMENTAL THERAPIE$220,000
N01 · FY2009 · AI · contact PI
ANIMAL MODELS OF HUMAN VIRAL INFECTIONS FOR EVALUATIOON OF EXPERIMENTAL THERAPIE$55,000
N01 · FY2009 · AI · contact PI